Literature DB >> 24746967

Bioengineered human tumor within a bone niche.

Aranzazu Villasante1, Alessandro Marturano-Kruik2, Gordana Vunjak-Novakovic3.   

Abstract

Monolayer cultures of tumor cells and animal studies have tremendously advanced our understanding of cancer biology. However, we often lack animal models for human tumors, and cultured lines of human cells quickly lose their cancer signatures. In recent years, simple 3D models for cancer research have emerged, including cell culture in spheroids and on biomaterial scaffolds. Here we describe a bioengineered model of human Ewing's sarcoma that mimics the native bone tumor niche with high biological fidelity. In this model, cancer cells that have lost their transcriptional profiles after monolayer culture re-express genes related to focal adhesion and cancer pathways. The bioengineered model recovers the original hypoxic and glycolytic tumor phenotype, and enables re-expression of angiogenic and vasculogenic mimicry features that favor tumor adaptation. We propose that differentially expressed genes between the monolayer cell culture and native tumor environment are potential therapeutic targets that can be explored using the bioengineered tumor model.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Ewing's sarcoma; Microenvironment; Therapeutic targets; Tissue engineering; Tumor niche

Mesh:

Year:  2014        PMID: 24746967      PMCID: PMC4048837          DOI: 10.1016/j.biomaterials.2014.03.081

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

1.  Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Authors:  Daisy W J van der Schaft; Femke Hillen; Patrick Pauwels; Dawn A Kirschmann; Karolien Castermans; Mirjam G A Oude Egbrink; Maxine G B Tran; Rafael Sciot; Esther Hauben; Pancras C W Hogendoorn; Olivier Delattre; Patrick H Maxwell; Mary J C Hendrix; Arjan W Griffioen
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

2.  3D tumour models: novel in vitro approaches to cancer studies.

Authors:  Agata Nyga; Umber Cheema; Marilena Loizidou
Journal:  J Cell Commun Signal       Date:  2011-04-16       Impact factor: 5.782

Review 3.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

Review 4.  The molecular pathogenesis of Ewing's sarcoma.

Authors:  Carlos Mackintosh; Juan Madoz-Gúrpide; Jose Luis Ordóñez; Daniel Osuna; David Herrero-Martín
Journal:  Cancer Biol Ther       Date:  2010-05-12       Impact factor: 4.742

5.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

6.  Engineering tumors with 3D scaffolds.

Authors:  Claudia Fischbach; Ruth Chen; Takuya Matsumoto; Tobias Schmelzle; Joan S Brugge; Peter J Polverini; David J Mooney
Journal:  Nat Methods       Date:  2007-09-02       Impact factor: 28.547

7.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

9.  Engineering bone tissue from human embryonic stem cells.

Authors:  Darja Marolt; Iván Marcos Campos; Sarindr Bhumiratana; Ana Koren; Petros Petridis; Geping Zhang; Patrice F Spitalnik; Warren L Grayson; Gordana Vunjak-Novakovic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

10.  Histone variant macroH2A confers resistance to nuclear reprogramming.

Authors:  Vincent Pasque; Astrid Gillich; Nigel Garrett; John B Gurdon
Journal:  EMBO J       Date:  2011-05-06       Impact factor: 11.598

View more
  31 in total

Review 1.  Tissue-engineered models of human tumors for cancer research.

Authors:  Aranzazu Villasante; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2015-02-07       Impact factor: 6.098

2.  Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.

Authors:  Marco Santoro; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Eric R Molina; Danielle Wu; Waldemar Priebe; Joseph A Ludwig; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2017-01       Impact factor: 3.845

3.  Tissue-Engineered Model of Human Osteolytic Bone Tumor.

Authors:  Aranzazu Villasante; Alessandro Marturano-Kruik; Samuel T Robinson; Zen Liu; X Edward Guo; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part C Methods       Date:  2017-02       Impact factor: 3.056

4.  Modeling tumor microenvironments using custom-designed biomaterial scaffolds.

Authors:  Zen Liu; Gordana Vunjak-Novakovic
Journal:  Curr Opin Chem Eng       Date:  2016-02       Impact factor: 5.163

5.  Development of a 3D bone marrow adipose tissue model.

Authors:  Heather Fairfield; Carolyne Falank; Mariah Farrell; Calvin Vary; Joshua M Boucher; Heather Driscoll; Lucy Liaw; Clifford J Rosen; Michaela R Reagan
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

6.  Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.

Authors:  Ushashi Dadwal; Carolyne Falank; Heather Fairfield; Sarah Linehan; Clifford J Rosen; David L Kaplan; Julie Sterling; Michaela R Reagan
Journal:  Bonekey Rep       Date:  2016-10-19

7.  Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone.

Authors:  Haitao Cui; Timothy Esworthy; Xuan Zhou; Sung Yun Hann; Robert I Glazer; Rong Li; Lijie Grace Zhang
Journal:  Adv Healthc Mater       Date:  2019-12-17       Impact factor: 9.933

Review 8.  Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development.

Authors:  Kacey Ronaldson-Bouchard; Gordana Vunjak-Novakovic
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

9.  Biomimetic tissue-engineered systems for advancing cancer research: NCI Strategic Workshop report.

Authors:  Teresa K Schuessler; Xin Yi Chan; Huanhuan Joyce Chen; Kyungmin Ji; Kyung Min Park; Alireza Roshan-Ghias; Pallavi Sethi; Archana Thakur; Xi Tian; Aranzazu Villasante; Ioannis K Zervantonakis; Nicole M Moore; Larry A Nagahara; Nastaran Z Kuhn
Journal:  Cancer Res       Date:  2014-08-05       Impact factor: 12.701

10.  Mimicking biophysical stimuli within bone tumor microenvironment.

Authors:  A Marturano-Kruik; K Yeager; D Bach; A Villasante; E Cimetta; G Vunjak-Novakovic
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.